These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37621691)

  • 1. Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms.
    Zeng T; Huang Z; Yu X; Zheng L; Liu T; Tian B; Xiao S; Huang J
    Front Oncol; 2023; 13():1166796. PubMed ID: 37621691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.
    Li B; Liu S; Gao Y; Zheng L; Lu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer.
    Su WC; Kao WY; Chang TK; Tsai HL; Huang CW; Chen YC; Li CC; Hsieh YC; Yeh HJ; Chang CC; Wang JY
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
    Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
    Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
    Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
    Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer].
    Li YL; Guan X; Dou LZ; Liu Y; Huang HY; Huang SK; Yang ZX; Wei BJ; Wu Y; Chen ZH; Wang GQ; Wang X; Cui W
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(33):2607-2613. PubMed ID: 36058686
    [No Abstract]   [Full Text] [Related]  

  • 14. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
    Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
    Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylated
    Zhao G; Liu X; Liu Y; Ma Y; Yang J; Li H; Xiong S; Fei S; Zheng M; Zhao X
    J Cancer; 2021; 12(9):2665-2672. PubMed ID: 33854626
    [No Abstract]   [Full Text] [Related]  

  • 17. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of human fecal SDC2 gene in colorectal cancer.
    Li N; Li C; Zhang X; Wang F; Li L; Liang J; Wang F
    Am J Transl Res; 2023; 15(4):2843-2849. PubMed ID: 37193183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stool DNA Test of Methylated
    Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
    Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.